易联众信息技术股份有限公司 2025 年第三季度报告 证券代码：300096 证券简称：ST 易联众 公告编号：2025-050 易联众信息技术股份有限公司 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个 别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 公司分别于 2025 年 8 月 18 日、2025 年 8 月 25 日披露了《关于收到有关控股子公司易联众民生（厦门）科技有限公 司股权回购事项通知的公告》（公告编号：2025-027）、《关于相关事项的特别风险提示公告》（公告编号：2025-030）。 因该通知所涉事项尚存在较大不确定性，可能导致公司需对自 2020 ...

康芝药业股份有限公司 2025 年第三季度报告 证券代码：300086 证券简称：康芝药业 公告编号：2025-041 康芝药业股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 康芝药业股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 | | | 本报告期 | 本报告期比上年同 | | 年初至报告 | | --- | --- | --- | --- | --- | --- | | | | | 期增减 | 年初至报告期末 | 期末比上年 | | | | | | | 同期增减 | | 营业收入（元） | | 106,183,265.51 | -26.06% | 3 ...

新疆八一钢铁股份有限公司 2025 年第三季度报告 证券代码：600581 证券简称：八一钢铁 新疆八一钢铁股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 比上年同 | 年初至报告期末 | 末比上年同期 | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 5,883,831,679.83 | 7.78 | ...

Financial Performance - The company's revenue for Q3 2025 was CNY 1,042,521,991.53, representing a 1.55% increase compared to CNY 1,026,603,307.41 in the same period last year[3]. - Net profit attributable to shareholders for Q3 2025 decreased by 26.04% to CNY 60,114,908.11 from CNY 80,516,030.93 year-on-year[3]. - The basic earnings per share for Q3 2025 was CNY 0.0704, down 26.05% from CNY 0.0943 in the previous year[4]. - Net profit for the first nine months of 2025 was ¥155,295,659.11, a decrease of 37.89% compared to the same period in 2024[8]. - Net profit for the period was CNY 155,295,659.11, a decrease of 38.0% from CNY 250,031,636.36 in the same period last year[26]. - Earnings per share (EPS) for the period was CNY 0.1819, down from CNY 0.2929 in the previous period[26]. - The company reported a total profit of CNY 216,135,015.17, a decrease from CNY 313,586,851.36 in the prior period[26]. Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 25,652,850.00, reflecting an 80.88% decline from CNY 134,166,400.00[3]. - Operating cash flow decreased by 80.88% to ¥25,652,852.51, attributed to increased cash payments for raw materials[9]. - The cash inflow from operating activities for the current period was ¥3,035,934,283.70, an increase of 22.8% compared to ¥2,472,193,730.77 in the previous period[28]. - The net cash flow from operating activities decreased to ¥25,652,852.51 from ¥134,166,421.37, reflecting a decline of 80.9%[28]. - The cash and cash equivalents at the end of the period were ¥119,050,510.47, down from ¥190,122,256.91 in the previous period[29]. - The company reported a cash decrease of ¥112,217,592.34 for the current period, contrasting with an increase of ¥32,761,948.98 in the previous period[29]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 6,374,733,364.37, a decrease of 0.16% compared to the previous year[4]. - Total liabilities amounted to CNY 1,008,262,899.25, compared to CNY 1,072,571,507.23 in the previous period[24]. - The total equity attributable to shareholders increased by 1.02% to CNY 5,366,470,465.12 compared to the previous year[4]. - The company’s non-current liabilities increased significantly, with other current liabilities rising by 525.47% to ¥28,528,919.14 due to an increase in tax payable[8]. - The total non-current assets were reported at RMB 2,965,000,000.00, reflecting a slight decrease from the previous period[21]. Operational Highlights - Total operating revenue for the period reached CNY 3,225,123,606.50, an increase of 5.28% compared to CNY 3,063,601,584.86 in the previous period[25]. - Total operating costs amounted to CNY 3,020,460,425.61, up 9.34% from CNY 2,762,220,951.51 in the prior period[25]. - Research and development expenses for the period were CNY 78,674,253.58, down from CNY 88,269,494.38 in the previous period[25]. Shareholder Information - Total shareholders at the end of the reporting period was 40,962, with the largest shareholder holding 21.33%[11]. - The company plans to increase shareholdings by key executives, with the chairman intending to invest between RMB 3 million and RMB 6 million within three months[13]. Legal and Compliance Issues - The company faced a penalty of RMB 3,306,272 due to environmental violations, which has been paid, and remediation efforts are underway[15]. - A safety incident at a subsidiary resulted in one fatality and two injuries, leading to a fine of RMB 690,000, but it did not significantly impact overall operations[16]. - The company is currently involved in legal proceedings related to alleged embezzlement, with the case under review until November 9, 2025[17]. - The company has made adjustments to previous accounting data due to accounting errors, impacting financial statements from 2021 to 2023[4]. Other Financial Metrics - Non-recurring gains and losses for the reporting period included government subsidies amounting to CNY 3,329,683.01, contributing to a total of CNY 8,691,793.33 year-to-date[5]. - The company reported a decrease in net profit after deducting non-recurring gains and losses by 26.37% to CNY 55,690,450.00 for Q3 2025[3]. - The weighted average return on equity for Q3 2025 was 1.13%, down from 1.52% in the same period last year[4]. - Other income decreased by 37.48% to ¥8,890,096.29, mainly due to a reduction in government subsidies[8]. - The company’s cash flow from investment activities was negative at -¥34,723,380.27, a decrease of 127.70% compared to the previous year[9]. Reporting and Governance - The company has not audited its third-quarter financial report[30]. - The company’s board of directors issued the report on October 24, 2025[31].

Financial Performance - The company's operating revenue for Q3 2025 was ¥115,969,622.58, a decrease of 4.89% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2025 was ¥13,147,752.50, down 35.50% year-on-year[3]. - The total profit for the year-to-date period was ¥14,915,913.37, reflecting a decline of 16.88%[3]. - Total revenue for the first three quarters of 2025 was CNY 237,694,760.86, a decrease of 4.5% compared to CNY 248,302,819.25 in the same period of 2024[18]. - Net profit for the first three quarters of 2025 was a loss of CNY 3,022,872.00, an improvement from a loss of CNY 17,020,443.48 in the same period of 2024[20]. - The company’s total comprehensive loss for the period was CNY 3,022,872.00, compared to a loss of CNY 17,020,443.48 in the previous year[20]. Research and Development - Research and development expenses totaled ¥14,123,079.26 in Q3 2025, a decrease of 12.64% compared to the previous year[4]. - The ratio of R&D expenses to operating revenue was 12.18%, down 1.08 percentage points year-on-year[4]. - Research and development expenses were CNY 31,220,699.23, down from CNY 37,754,809.62, a reduction of 17.5%[18]. - The company is actively developing multi-valent vaccines and exploring a dual business model of "innovative drugs + animal health" to drive growth[9]. Cash Flow and Liquidity - The company reported a net cash flow from operating activities of -¥18,106,094.12 for the year-to-date period, a decline of 245.16%[4]. - The net cash flow from operating activities was -$18.1 million, a decrease from $12.5 million in the previous period[22]. - The cash outflow from operating activities totaled $177.9 million, compared to $209.2 million in the prior year[22]. - Cash received from sales of goods and services was CNY 146,597,121.05, down from CNY 208,274,801.53, representing a decrease of 29.6%[21]. - The ending cash and cash equivalents balance was $73.96 million, down from $98.05 million year-over-year[22]. - The company experienced a net decrease in cash and cash equivalents of $37.2 million, contrasting with an increase of $53.2 million in the previous period[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,560,336,881.57, an increase of 0.40% from the end of the previous year[4]. - Total assets as of September 30, 2025, amounted to RMB 1,560,336,881.57, compared to RMB 1,554,117,949.14 as of December 31, 2024, showing a slight increase[14]. - Total liabilities increased to CNY 139,417,180.20 from CNY 128,495,487.08, an increase of 7.2%[17]. - Total equity attributable to shareholders decreased slightly to CNY 1,409,893,375.64 from CNY 1,411,295,212.77[16]. Shareholder Information - The company reported a total of 12,388 common shareholders at the end of the reporting period[11]. - The largest shareholder, Yang Yufang, holds 90,063,197 shares, representing 21.93% of total shares[11]. - The second-largest shareholder, UNITED BIOMEDICAL, INC., holds 43,199,898 shares, accounting for 10.52%[11]. - The combined shareholding of the top four shareholders is 35.82%, indicating a significant concentration of ownership[12]. - The company has not reported any changes in the participation of major shareholders in margin financing and securities lending activities[13]. Operating Costs - Total operating costs decreased to CNY 235,297,261.25 from CNY 259,262,501.74, reflecting a reduction of 9.2%[18]. Other Income - The company reported a significant increase in other income to CNY 3,773,232.91 from CNY 2,848,837.55, an increase of 32.4%[19]. Accounting Standards - The company will not apply new accounting standards starting from 2025[23].

Financial Performance - The company's operating revenue for the third quarter reached ¥1,894,697,656.12, representing a year-on-year increase of 1,625.08%[3] - The total profit for the period was ¥942,318,826.09, with a year-to-date decrease of 104.27% to -¥185,591,676.66[3] - Net profit attributable to shareholders was ¥623,436,299.08, reflecting a year-to-date decrease of 112.16%[3] - The basic and diluted earnings per share were both ¥1.55, a decrease of 112.13% compared to the previous year[3] - Total revenue for the first three quarters of 2025 was CNY 2,065,895,265.44, a decrease from CNY 5,662,560,246.21 in the same period of 2024, representing a decline of approximately 63.5%[18] - Net profit for the first three quarters of 2025 was a loss of CNY 494,515,911.29, compared to a profit of CNY 4,065,367,515.10 in the same period of 2024[19] - Operating profit for the first three quarters of 2025 was a loss of CNY 185,151,076.77, down from a profit of CNY 4,349,785,140.92 in 2024[19] - The total comprehensive income attributable to the parent company for the current period is -490,119,390.74 CNY, compared to 4,080,957,866.61 CNY in the previous period[20] - Basic and diluted earnings per share for the current period are both -1.23 CNY, down from 10.14 CNY in the previous period[20] Cash Flow and Liquidity - The net cash flow from operating activities was -¥758,580,044.73, a decline of 142.10% compared to the previous year[3] - Net cash flow from operating activities for the first three quarters of 2025 is -1,892,401,585.71 CNY, compared to 4,494,488,783.12 CNY in the same period of 2024[22] - Cash inflow from operating activities totaled 455,390,621.58 CNY, significantly lower than 6,151,840,374.07 CNY in the previous year[21] - Total cash outflow from operating activities reached 2,347,792,207.29 CNY, compared to 1,657,351,590.95 CNY in the previous year[22] - Cash flow from investing activities resulted in a net outflow of -970,082,886.83 CNY, compared to -698,285,222.01 CNY in the previous year[22] - Cash inflow from financing activities amounted to 5,984,837,989.09 CNY, a significant increase from 1,128,930,000.00 CNY in the previous year[22] - The net increase in cash and cash equivalents for the current period is 2,338,272,370.36 CNY, compared to 4,530,884,664.35 CNY in the previous year[22] - The ending balance of cash and cash equivalents is 5,546,270,654.08 CNY, up from 4,922,577,373.88 CNY in the previous year[22] - The company has a significant cash position with 6,085,691,597.59 RMB in cash and cash equivalents as of September 30, 2025, compared to 3,220,120,969.20 RMB at the end of 2024, indicating a growth of approximately 89.5%[13] Assets and Liabilities - Total assets at the end of the period amounted to ¥12,319,212,489.52, an increase of 72.60% from the previous year[4] - Total assets increased to CNY 12,319,212,489.52 from CNY 7,137,357,660.07, reflecting a growth of about 72.9%[16] - Total liabilities rose to CNY 5,148,319,132.79 from CNY 3,251,432,880.03, an increase of approximately 58.2%[15] - Cash and cash equivalents in current assets totaled CNY 11,359,543,556.79, up from CNY 6,307,204,588.11, indicating a growth of approximately 80.5%[16] - Long-term borrowings increased significantly to CNY 2,810,090,000.00 from CNY 1,189,430,000.00, marking an increase of about 136.2%[15] Research and Development - Research and development expenses totaled ¥733,745,772.26 for the quarter, an increase of 89.51% year-on-year[4] - The ratio of R&D expenses to operating revenue was 38.73%, a decrease of 313.78 percentage points[4] - Research and development expenses surged to CNY 1,772,382,298.36, compared to CNY 931,701,202.14 in the previous year, indicating an increase of approximately 90.5%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 5,979[9] - The largest shareholder, Zhu Yi, holds 298,159,400 shares, representing 72.22% of the total shares[9] - The total number of shares held by the top 10 shareholders accounts for a significant portion of the company's equity, with the top shareholder alone holding over 72%[9] - The company has not reported any changes in the participation of major shareholders in margin financing or securities lending activities[10] Strategic Partnerships and Future Outlook - The company confirmed a significant milestone in its collaboration with BMS, leading to a recognition of a recent payment of $250 million in revenue[7] - The company is on track to achieve a milestone payment of 250 million USD from its collaboration with BMS by September 30, 2025[11] - The company has engaged in strategic partnerships to enhance its product pipeline and market reach[11] - The company is focused on expanding its market presence and developing new technologies to drive future growth[11]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥1,324,801,878.72, representing a year-on-year increase of 32.29%[4] - Total profit for the quarter was ¥111,869,231.31, reflecting a significant growth of 61.55% compared to the same period last year[4] - Net profit attributable to shareholders was ¥138,388,632.85, marking a 92.92% increase year-on-year[4] - The basic earnings per share for the quarter was ¥0.52, up 92.59% from the previous year[4] - The company reported a total profit for the year-to-date of ¥230,965,134.85, which is a 51.53% increase compared to the same period last year[4] - Net profit for the first three quarters of 2025 was ¥248,821,423.52, compared to ¥154,383,441.01 in 2024, representing a significant increase of 60.9%[23] - Earnings per share (EPS) for the first three quarters of 2025 was ¥0.97, up from ¥0.57 in the same period of 2024, indicating a growth of 70.2%[24] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥7,073,565,172.87, a 36.32% increase from the end of the previous year[5] - The total assets of the company as of the reporting period end were RMB 7.074 billion, reflecting a growth of 36.32% compared to the previous year[13] - Total assets as of the end of the reporting period were ¥7,073,565,172.87, up from ¥5,188,814,731.26, reflecting a growth of 36.4%[19] - Total liabilities increased to ¥4,411,444,102.49 from ¥2,727,825,420.11, representing a rise of 62.0%[19] - The company's goodwill remained stable at ¥98,968,519.23, unchanged from the previous year[18] - Non-current assets totaled ¥2,164,792,996.17, an increase from ¥1,555,643,400.41, indicating a growth of 39.0%[18] Cash Flow - The net cash flow from operating activities for the year-to-date was negative at -¥387,819,185.78, a decline of 195.71% compared to the previous year[4] - The net cash flow from financing activities was $1,055,211,232.48, a significant improvement from -$317,335,712.74 in the first three quarters of 2024[27] - Cash inflow from financing activities rose to $2,333,832,466.30, compared to $1,161,779,231.90 in the previous year, marking a 100.5% increase[27] - Cash inflow from operating activities for the first three quarters of 2025 was $4,137,698,830.28, an increase of 8.2% compared to $3,825,257,679.77 in the same period of 2024[26] - Net cash outflow from operating activities was -$387,819,185.78, a decline from a net inflow of $405,189,405.64 in the first three quarters of 2024[27] Operational Strategy - The company plans to accelerate domestic and international capacity expansion to address international trade challenges and delivery pressures[13] - The company is enhancing its accounts receivable management and cash flow coordination to ensure stable operational performance[13] Shareholder Equity - The total equity attributable to shareholders at the end of the reporting period was ¥2,522,283,631.34, a 9.16% increase from the previous year[5] - The company’s net assets as of the reporting period end were RMB 2.522 billion, a year-over-year increase of 9.16%[13] Research and Development - Research and development expenses for the first three quarters of 2025 totaled ¥255,485,908.46, compared to ¥230,489,161.79 in 2024, marking an increase of 10.8%[23] Market Activity - The company has issued a prospectus for its H-share listing, with a base issuance of 67,010,500 shares at a price of HKD 68.88 per share, expected to be listed on October 28, 2025[14] Other Financial Metrics - The weighted average return on equity for the quarter was 5.61%, an increase of 2.38 percentage points[4] - The gross margin of the 800G optical module sales has increased, contributing to the significant profit growth during the reporting period[12] - The company’s accounts receivable increased to RMB 1.992 billion, up from RMB 1.230 billion in the previous year[17] Cash Management - Cash and cash equivalents at the end of the period stood at $496,661,984.43, up from $331,274,583.69 in the same period last year[27] - Total cash outflow from investment activities was $678,792,640.50, compared to $203,034,441.92 in the previous year, indicating a 234.5% increase[27] - The company received $2,003,185.77 from the disposal of fixed assets, down from $5,732,032.28 in the previous year[27] - The company reported a cash inflow of $364,509,747.94 from tax refunds, an increase from $255,952,927.94 in the same period last year[26] Accounting Standards - The company did not apply new accounting standards for the current reporting period[28]

公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人沈鸣、主管会计工作负责人任国平及会计机构负责人（会计主管人员）杨敏保证季度 报告中财务信息的真实、准确、完整。 江苏华盛锂电材料股份有限公司 2025 年第三季度报告 证券代码：688353 证券简称：华盛锂电 江苏华盛锂电材料股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比上 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 年同期增减变 | 年初至报告期末 | 末比上年同期 | | | | 动幅度(%) | | 增减变动幅度 | | | | | | (%) | | 营业收入 | 188,702,527.53 | 46.8 ...

Revenue and Profit - Revenue for the third quarter was CNY 347,306,742, a decrease of 11.79% compared to the same period last year[4] - Total profit for the quarter reached CNY 90,074,713, an increase of 20.59% year-over-year[4] - Net profit attributable to shareholders was CNY 79,354,432, reflecting an 18.26% increase compared to the previous year[4] - Total operating revenue for the first three quarters of 2025 was approximately CNY 1,000.91 million, a decrease of 3.2% compared to CNY 1,040.35 million in the same period of 2024[19] - Operating profit increased to approximately CNY 224.48 million in 2025, up by 8.1% from CNY 207.76 million in 2024[20] - Net profit for the first three quarters of 2025 was approximately CNY 195.88 million, an increase of 7.8% compared to CNY 181.63 million in 2024[20] - The total comprehensive income for the period was reported at 218,808,587.45 RMB, compared to 185,555,991.44 RMB in the previous period[29] Assets and Liabilities - Total assets at the end of the quarter were CNY 5,773,699,505.83, representing a 12.36% increase from the end of the previous year[5] - The company's total current assets amounted to CNY 2,970,351,124.85, up from CNY 2,472,057,947.44, indicating a growth of about 20.1%[14] - The company's total liabilities decreased to CNY 1,988,253,948.47 from CNY 2,175,345,370.36, a reduction of about 8.6%[16] - The total assets as of September 30, 2025, amounted to CNY 5,205,274,283.96, up from CNY 4,417,590,782.26 at the end of 2024, reflecting a growth of 17.8%[27] - The total liabilities decreased to CNY 1,489,476,518.01 as of September 30, 2025, compared to CNY 1,610,315,259.74 at the end of 2024, indicating a reduction of 7.5%[27] Shareholders' Equity - Shareholders' equity attributable to the company was CNY 3,775,861,437.55, up 30.34% compared to the previous year[5] - The equity attributable to shareholders increased to CNY 3,775,861,437.55 from CNY 2,896,842,941.63, marking a significant increase of approximately 30.4%[16] - The company's total equity increased to CNY 3,715,797,765.95 as of September 30, 2025, compared to CNY 2,807,275,522.52 at the end of 2024, reflecting a growth of 32.3%[27] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 122,277,200.38, an increase of 65.36%[4][9] - Cash flow from operating activities generated a net amount of approximately CNY 122.28 million in 2025, significantly up from CNY 73.95 million in 2024, marking a growth of 65.2%[23] - Total cash inflow from operating activities increased to 982,018,994.10 RMB in 2025 from 935,323,070.17 RMB in 2024, reflecting a growth of approximately 5.5%[31] - Cash outflow from investing activities was 1,937,081,006.75 RMB in 2025, up from 1,533,309,086.05 RMB in 2024, indicating an increase of about 26.4%[32] - Net cash flow from financing activities improved significantly to 792,066,337.03 RMB in 2025, compared to a negative cash flow of -248,213,601.02 RMB in 2024[32] Research and Development - Research and development expenses totaled CNY 27,951,742.64, accounting for 8.05% of revenue, an increase of 0.53 percentage points[5] - Research and development expenses for the first three quarters of 2025 were approximately CNY 76.97 million, slightly down from CNY 80.05 million in 2024, a decrease of 3.8%[19] - The company's R&D expenses for the first three quarters of 2025 were CNY 55,751,020.69, down from CNY 65,835,157.61 in the same period of 2024, a decrease of 15.4%[28] Inventory and Receivables - The company's accounts receivable decreased to CNY 428,691,931.90 from CNY 567,376,543.58, a decline of about 24.5%[14] - The company reported a total inventory of CNY 222,854,153.91, which is an increase from CNY 207,156,378.39, reflecting a growth of approximately 7.6%[14] - The company's inventory as of September 30, 2025, was CNY 212,809,095.16, an increase from CNY 195,375,755.80 in the previous year, indicating a growth of 8.3%[26] Cash and Cash Equivalents - Cash and cash equivalents decreased to CNY 520,734,607.40 from CNY 615,274,438.47, reflecting a decline of approximately 15.3%[14] - The company's cash and cash equivalents at the end of the reporting period were CNY 281,357,569.52, a slight decrease from CNY 275,984,710.70 in the previous year[24] - Cash and cash equivalents at the end of the period decreased to 131,640,319.74 RMB in 2025 from 134,959,178.53 RMB in 2024[32] Other Financial Metrics - The basic earnings per share for the quarter was CNY 0.22, unchanged from the previous quarter[5] - The weighted average return on equity was 2.10%, a decrease of 0.19 percentage points compared to the previous year[5] - The company reported non-recurring gains of CNY 9,993,186.87 for the quarter[8] - The company reported a tax expense of approximately CNY 28.69 million in 2025, compared to CNY 25.20 million in 2024, an increase of 9.9%[20] - Other comprehensive income after tax for 2025 was approximately -CNY 2.64 million, an improvement from -CNY 5.28 million in 2024[20] - The company has not adopted new accounting standards for the year 2025[33]

Financial Performance - The company's operating revenue for the third quarter was ¥5,252,117,280.04, a decrease of 8.12% compared to the same period last year[5]. - Total profit for the third quarter was ¥214,440,402.34, down 54.43% year-over-year[5]. - Net profit attributable to shareholders was ¥204,516,218.38, reflecting a decline of 55.53% compared to the previous year[5]. - The basic earnings per share for the third quarter was ¥0.26, a decrease of 55.93% year-over-year[6]. - Net profit for the first three quarters of 2025 was ¥880,669,593.25, a decrease of 19.77% from ¥1,097,542,782.68 in the same period of 2024[25]. - Basic earnings per share for the first three quarters of 2025 were ¥1.09, down from ¥1.40 in 2024[26]. Revenue and Costs - Total operating revenue for the first three quarters of 2025 reached ¥15,473,610,922.54, an increase of 6.06% compared to ¥14,588,763,717.30 in the same period of 2024[24]. - Total operating costs for the first three quarters of 2025 were ¥14,515,160,218.15, up 8.43% from ¥13,387,505,269.67 in 2024[24]. Cash Flow - The net cash flow from operating activities for the year-to-date was -¥1,231,588,620.68, a decrease of 410.95% year-over-year[5]. - Cash inflow from operating activities for the first three quarters of 2025 was ¥16,419,179,369.79, an increase from ¥15,029,788,283.56 in 2024[28]. - The net cash flow from operating activities was -$1.23 billion, a decrease from $396 million in the previous period[29]. - Total cash outflow from operating activities amounted to $17.65 billion, compared to $14.63 billion last year, reflecting a 13.9% increase[29]. Assets and Liabilities - The total assets at the end of the reporting period were ¥20,044,982,361.16, an increase of 15.90% compared to the end of the previous year[6]. - Total liabilities reached RMB 12,134,509,633.55, up from RMB 10,000,000,000, indicating an increase of approximately 21.35%[20]. - The total liabilities increased to ¥11,132,853,997.97 in 2025 from ¥8,875,852,460.80 in 2024[24]. - Total equity attributable to shareholders reached ¥8,912,128,363.19 in 2025, up from ¥8,419,547,276.12 in 2024[24]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 44,010[13]. - The first major shareholder, Bowei Group Co., Ltd., holds 28.15% of the shares, while the second major shareholder, Bowei Asia Pacific Co., Ltd., holds 9.73%[14][15]. Operational Insights - The decline in revenue and profit was primarily attributed to decreased profitability in the new energy sector due to high anti-dumping duties imposed by the U.S. on Vietnamese solar components[10]. - The company reported a significant increase in net profit from new materials, driven by higher sales volume and improved product structure[10]. Cash Management - Cash and cash equivalents decreased to RMB 1,613,136,592.54 from RMB 2,276,810,443.79, representing a decline of approximately 29.06%[19]. - The total cash and cash equivalents at the end of the period were $1.30 billion, down from $1.80 billion, representing a decrease of 28%[29]. - The company reported a cash outflow of $3.87 billion from financing activities, down from $4.82 billion, showing a 19.7% decrease[29]. Accounting Standards - The company did not apply new accounting standards starting from 2025[30].